🟢 Hinge Health is trading 4.14% up with no clear catalyst reported

Hinge Health is trading 4.14% higher at $95.78 on September 25, with no clear company-specific catalyst reported.

• President James Pursley’s sale of 33,000 shares for about $3.1 million relates to September 21 transactions under a pre-arranged Rule 10b5-1 plan, not a new event explaining the rise.
• Major U.S. indexes are higher and healthcare is up 1.27%. The sector backdrop may be supportive, but available evidence does not establish a direct cause for Hinge Health’s gain.